Generated Narrative: Composition 76279633-d5a6-439b-9e88-5880c531e241 Profile: Composition (EPS) identifier: urn:ietf:rfc:9562/166615c7-0536-4d24-b5d7-8d659a29ce3e status: Final type: Patient summary Document date: 2025-08-31 17:46:55+0000 author: PractitionerRole title: European Patient Summary confidentiality: normal custodian: Organization BfA-Klinik
Condition Onset Date Status Hyperlipidemia 2020-06-15 active Emphysematous bronchitis 2020-06-15 active Ischemic heart disease 2010-04-19 active Chronic sinusitis 1994-01-16 active Anemia 1993-02-22 active Prediabetes 1991-02-18 active
Medication Since Form Dosage Reason Simvastatin 10 mg oral tablet 2025-07-15 Oral tablet 1 tablet (10 mg) by mouth once daily Hyperlipidemia Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation 2025-07-14 Solution for inhalation 2.5 mg (0.5 mL of 5 mg/mL solution) via nebulizer every 4 to 6 hours as needed Chronic obstructive bronchitis (disorder) Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet 2025-07-14 Oral tablet 1 tablet (300 mg/5 mg) by mouth every 4 to 6 hours as needed for pain 60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler 2025-07-14 1 inhalation (0.25 mg/0.05 mg) twice daily Chronic obstructive bronchitis (disorder) Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2010-04-26 Oral tablet 1 tablet (75 mg) by mouth once daily Simvastatin 20 mg oral tablet 2010-04-26 Oral tablet 1 tablet (20 mg) by mouth once daily Nitroglycerin 400 microgram/actuation sublingual spray 2010-04-26 Sublingual spray 400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2010-04-26 Prolonged-release oral tablet 1 tablet (100 mg) once daily doxycycline hyclate 100 MG 2008-08-12 100 mg twice daily Viral sinusitis (disorder) Astemizole 10 mg oral tablet 1978-10-26 Oral tablet 1 tablet (10 mg) once daily Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream 1978-10-11 Cutaneous cream Apply a thin layer (approximately 1 g) to the affected area twice daily Contact dermatitis
Vaccine Date Influenza virus antigen only vaccine product 2025-07-14 SARS-CoV-2 mRNA vaccine 2021-03-01 Clostridium tetani toxoid antigen adsorbed only vaccine product 2018-06-04
Allergies and adverse reactions Document
Allergy/Intolerance Onset Date Status Type Reaction Penicillin V 1978-10-26 active medication Allergy to substance 1978-10-26 active environment
Immunization Recommendation Due Date Reason Vaccine product containing only Influenza virus antigen (medicinal product) 2025-10-01 Annual seasonal influenza vaccination
No known procedures
Vital Signs 2025-07-14 2024-07-08 Body Height 158.3 cm 158.3 cm Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score} 2 {score} Body Weight 73.3 kg 71.3 kg Body mass index (BMI) [Ratio] 29.2 kg/m2 28.5 kg/m2 Diastolic Blood Pressure 55 mm[Hg] 62 mm[Hg] Systolic Blood Pressure 113 mm[Hg] 104 mm[Hg] Heart rate 80 /min 72 /min Respiratory rate 13 /min 14 /min
Relevant diagnostic tests/laboratory data
Relevant diagnostic tests/laboratory data note
Recent Lab Observations 15 Jul 2024 Reference Range Unit Glucose [Mass/volume] in Blood 65.9 L 70 - 99 mg/dL Urea nitrogen [Mass/volume] in Blood 9.2 7 - 20 mg/dL Creatinine [Mass/volume] in Blood 2.7 H 0.6 - 1.3 mg/dL Calcium [Mass/volume] in Blood 8.7 8.5 - 10.3 mg/dL Sodium [Moles/volume] in Blood 136.4 135 - 145 mmol/L Potassium [Moles/volume] in Blood 4.4 3.5 - 5.1 mmol/L Chloride [Moles/volume] in Blood 101.2 98 - 108 mmol/L Carbon dioxide, total [Moles/volume] in Blood 28.5 22 - 32 mmol/L Protein [Mass/volume] in Serum or Plasma 6.9 6 - 8.3 g/dL Albumin [Mass/volume] in Serum or Plasma 4.0 3.5 - 5 g/dL Globulin [Mass/volume] in Serum by calculation 2.9 2 - 3.5 g/L Bilirubin.total [Mass/volume] in Serum or Plasma 0.8 0.3 - 1.2 mg/dL Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 87.0 35 - 117 U/L Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 45.0 7 - 46 U/L Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 8.7 L 10 - 40 U/L Cholesterol [Mass/volume] in Serum or Plasma 193.2 125 - 200 mg/dL Triglyceride [Mass/volume] in Serum or Plasma 149.3 0 - 199 mg/dL Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 129.5 0 - 159 mg/dL Cholesterol in HDL [Mass/volume] in Serum or Plasma 62.7 50 - 100 mg/dL
Device Date (since) Home nebulizer (physical object) 2021-06-21 Blood glucose meter (physical object) 1991-02-18
Petra Schwartz 1950-04-19
Generated Narrative: PractitionerRole 79bb6d9a-24fa-4479-a1a6-92e958200414 Profile: PractitionerRole (EU base) practitioner: Practitioner Hel Ping organization: Organization BfA-Klinik
Generated Narrative: Practitioner 398f1dee-39b2-4259-8293-7385d482d06e Profile: Practitioner (EU base) name: Hel Ping
Generated Narrative: Organization ee1c1f62-cb27-4dc4-8d07-f9c58215f309 Profile: Organization (EU base) identifier: urn:ietf:rfc:9562/cd9d8d77-6da5-4eee-b973-cf8467686ffe name: BfA-Klinik address: Bad Schmiedeberg 06905 Germany
Hyperlipidemia 2020-06-15 active
Emphysematous bronchitis 2020-06-15 active
Chronic obstructive bronchitis (disorder)
Ischemic heart disease 2010-04-19 active
Chronic sinusitis 1994-01-16 active
Anemia 1993-02-22 active
Prediabetes 1991-02-18 active
Fracture of forearm 2023-12-28 – 2024-03-30 inactive
Fracture of bone 2023-12-28 – 2024-03-30 inactive
Viral sinusitis 2019-03-08 – 2019-03-23 inactive
Fracture of forearm 2016-09-12 – 2016-11-30 inactive
Fracture of bone 2016-09-12 – 2016-11-30 inactive
Simvastatin 10 mg oral tablet, Oral tablet
Product containing precisely simvastatin 10 milligram/1 each conventional release oral tablet (clinical drug)
Simvastatin 10 mg oral tablet 2025-07-15 Oral tablet 1 tablet (10 mg) by mouth once daily Hyperlipidemia
Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation, Solution for inhalation
Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation
Albuterol (as albuterol sulfate) 5 mg/mL solution for inhalation 2025-07-14 Solution for inhalation 2.5 mg (0.5 mL of 5 mg/mL solution) via nebulizer every 4 to 6 hours as needed Chronic obstructive bronchitis (disorder)
2.5 mg (0.5 mL of 5 mg/mL solution) via nebulizer every 4 to 6 hours as needed
Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet, Oral tablet
acetaminophen 300 MG / hydrocodone bitartrate 5 MG Oral Tablet
Product containing precisely hydrocodone bitartrate 5 milligram and paracetamol 300 milligram/1 each conventional release oral tablet (clinical drug)
Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet
Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet 2025-07-14 Oral tablet 1 tablet (300 mg/5 mg) by mouth every 4 to 6 hours as needed for pain
1 tablet (300 mg/5 mg) by mouth every 4 to 6 hours as needed for pain
60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler,
60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler
60 ACTUAT Fluticasone propionate 0.25 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler 2025-07-14 1 inhalation (0.25 mg/0.05 mg) twice daily Chronic obstructive bronchitis (disorder)
1 inhalation (0.25 mg/0.05 mg) twice daily
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet, Oral tablet
Product containing precisely clopidogrel (as clopidogrel bisulfate) 75 milligram/1 each conventional release oral tablet (clinical drug)
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet
Clopidogrel (as clopidogrel bisulfate) 75 mg oral tablet 2010-04-26 Oral tablet 1 tablet (75 mg) by mouth once daily
Simvastatin 20 mg oral tablet, Oral tablet
Product containing precisely simvastatin 20 milligram/1 each conventional release oral tablet (clinical drug)
Simvastatin 20 mg oral tablet 2010-04-26 Oral tablet 1 tablet (20 mg) by mouth once daily
Nitroglycerin 400 microgram/actuation sublingual spray, Sublingual spray
nitroglycerin 0.4 MG/ACTUAT Mucosal Spray
Product containing precisely glyceryl trinitrate 400 microgram/1 actuation conventional release sublingual spray (clinical drug)
Nitroglycerin 400 microgram/actuation sublingual spray
Nitroglycerin 400 microgram/actuation sublingual spray 2010-04-26 Sublingual spray 400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes
400 micrograms (1 spray) sublingually as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet, Prolonged-release oral tablet
24 HR metoprolol succinate 100 MG Extended Release Oral Tablet
Product containing precisely metoprolol tartrate (as metoprolol succinate) 100 milligram/1 each prolonged-release oral tablet (clinical drug)
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 2010-04-26 Prolonged-release oral tablet 1 tablet (100 mg) once daily
doxycycline hyclate 100 MG,
doxycycline hyclate 100 MG 2008-08-12 100 mg twice daily Viral sinusitis (disorder)
Astemizole 10 mg oral tablet, Oral tablet
Product containing precisely astemizole 10 milligram/1 each conventional release oral tablet (clinical drug)
Astemizole 10 mg oral tablet 1978-10-26 Oral tablet 1 tablet (10 mg) once daily
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream, Cutaneous cream
Product containing precisely hydrocortisone 10 milligram/1 gram and urea 100 milligram/1 gram conventional release cutaneous cream (clinical drug)
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream
Hydrocortisone 10 mg/g and urea 100 mg/g cutaneous cream 1978-10-11 Cutaneous cream Apply a thin layer (approximately 1 g) to the affected area twice daily Contact dermatitis
Apply a thin layer (approximately 1 g) to the affected area twice daily
Influenza virus antigen only vaccine product 2025-07-14
Vaccine product containing only Influenza virus antigen (medicinal product)
influenza, inactivated, split virus or surface antigen
Influenza virus antigen only vaccine product
SARS-CoV-2 mRNA vaccine 2021-03-01
Vaccine product containing only severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid (medicinal product)
Clostridium tetani toxoid antigen adsorbed only vaccine product 2018-06-04
Vaccine product containing only Clostridium tetani toxoid antigen adsorbed (medicinal product)
tetanus toxoid, combinations with diphtheria toxoid
Clostridium tetani toxoid antigen adsorbed only vaccine product
Penicillin V 1978-10-26 active medication
Allergy to substance 1978-10-26 active environment
Hyperlipidemia clinical management plan 2020-07-06 Hyperlipidemia
Hyperlipidemia clinical management plan (record artifact)
Chronic obstructive pulmonary disease clinical management plan 2020-06-15 Chronic obstructive bronchitis (disorder)
Chronic obstructive pulmonary disease clinical management plan (qualifier value)
Chronic obstructive pulmonary disease clinical management plan
Diabetes self management plan 1991-02-18 Prediabetes
Diabetes self management plan (qualifier value)
Self-care interventions 1978-10-26 -
Body Height 158.3 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 3 {score}
Pain severity - 0-10 verbal numeric rating [Score] - Reported
Body Weight 73.3 kg
Body mass index (BMI) [Ratio] 29.2 kg/m2
Diastolic Blood Pressure 55 mm[Hg]
Systolic Blood Pressure 113 mm[Hg] Heart rate 80 /min
Blood Pressure panel with all children optional
Respiratory rate 13 /min
Pain severity - 0-10 verbal numeric rating [Score] - Reported 2 {score}
Body Weight 71.3 kg
Body mass index (BMI) [Ratio] 28.5 kg/m2
Systolic Blood Pressure 104 mm[Hg] Diastolic Blood Pressure 62 mm[Hg]
Heart rate 72 /min
Respiratory rate 14 /min
Generated Narrative: Observation 81628dd7-a8bf-43b5-bae5-001c46f1a8f8 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Glucose [Mass/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 65.9 mg/dL (Details: UCUM codemg/dL = 'mg/dL') interpretation: Low ReferenceRanges - Low High * 70 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 99 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Generated Narrative: Observation fee31706-be91-4a20-b64d-a1ef32854125 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Urea nitrogen [Mass/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 9.2 mg/dL (Details: UCUM codemg/dL = 'mg/dL') ReferenceRanges - Low High * 7 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 20 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Generated Narrative: Observation d6e99596-92d5-4e70-a8b5-4da00b26709a Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Creatinine [Mass/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 2.7 mg/dL (Details: UCUM codemg/dL = 'mg/dL') interpretation: High ReferenceRanges - Low High * 0.6 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 1.3 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Generated Narrative: Observation 132273e6-ac2c-44ec-b416-a3a64bb6fc27 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Calcium [Mass/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 8.7 mg/dL (Details: UCUM codemg/dL = 'mg/dL') ReferenceRanges - Low High * 8.5 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 10.3 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Generated Narrative: Observation 3d3701ef-24c3-48f3-b1ec-6d101cf73af5 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Sodium [Moles/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 136.4 mmol/L (Details: UCUM codemmol/L = 'mmol/L') ReferenceRanges - Low High * 135 mmol/L (Details: UCUM codemmol/L = 'mmol/L') * 145 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
Generated Narrative: Observation d918fd0e-9ac5-44c5-81ec-01585d8db6cb Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Potassium [Moles/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 4.4 mmol/L (Details: UCUM codemmol/L = 'mmol/L') ReferenceRanges - Low High * 3.5 mmol/L (Details: UCUM codemmol/L = 'mmol/L') * 5.1 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
Generated Narrative: Observation 886aef25-ecf8-4606-b5c5-880f00f9862f Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Chloride [Moles/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 101.2 mmol/L (Details: UCUM codemmol/L = 'mmol/L') ReferenceRanges - Low High * 98 mmol/L (Details: UCUM codemmol/L = 'mmol/L') * 108 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
Generated Narrative: Observation 2bf0d074-d1f3-40eb-aa1a-1e83d1cde1a6 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Carbon dioxide, total [Moles/volume] in Blood subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 28.5 mmol/L (Details: UCUM codemmol/L = 'mmol/L') ReferenceRanges - Low High * 22 mmol/L (Details: UCUM codemmol/L = 'mmol/L') * 32 mmol/L (Details: UCUM codemmol/L = 'mmol/L')
Carbon dioxide, total [Moles/volume] in Blood
Generated Narrative: Observation a50c3d24-d302-41db-8bc6-4f77ffe37ba9 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Protein [Mass/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 6.9 g/dL (Details: UCUM codeg/dL = 'g/dL') ReferenceRanges - Low High * 6 g/dL (Details: UCUM codeg/dL = 'g/dL') * 8.3 g/dL (Details: UCUM codeg/dL = 'g/dL')
Protein [Mass/volume] in Serum or Plasma
Generated Narrative: Observation 4da22422-b9be-4eb8-839f-9829138660ae Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Albumin [Mass/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 4 g/dL (Details: UCUM codeg/dL = 'g/dL') ReferenceRanges - Low High * 3.5 g/dL (Details: UCUM codeg/dL = 'g/dL') * 5 g/dL (Details: UCUM codeg/dL = 'g/dL')
Albumin [Mass/volume] in Serum or Plasma
Generated Narrative: Observation 04c29e07-f621-4dbb-b7b8-8a4dc89ec44b Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Globulin [Mass/volume] in Serum by calculation subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 2.9 g/L (Details: UCUM codeg/L = 'g/L') ReferenceRanges - Low High * 2 g/L (Details: UCUM codeg/L = 'g/L') * 3.5 g/L (Details: UCUM codeg/L = 'g/L')
Globulin [Mass/volume] in Serum by calculation
Generated Narrative: Observation ad120185-28f4-495b-b0fa-0e258e9e3ba7 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Bilirubin.total [Mass/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 0.8 mg/dL (Details: UCUM codemg/dL = 'mg/dL') ReferenceRanges - Low High * 0.3 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 1.2 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Bilirubin.total [Mass/volume] in Serum or Plasma
Generated Narrative: Observation 04cf6095-fbc1-41ee-aa84-881cf4753ab6 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 87 U/L (Details: UCUM codeU/L = 'U/L') ReferenceRanges - Low High * 35 U/L (Details: UCUM codeU/L = 'U/L') * 117 U/L (Details: UCUM codeU/L = 'U/L')
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
Generated Narrative: Observation bee93551-87cd-4484-8e92-609e8d1db8da Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 45 U/L (Details: UCUM codeU/L = 'U/L') ReferenceRanges - Low High * 7 U/L (Details: UCUM codeU/L = 'U/L') * 46 U/L (Details: UCUM codeU/L = 'U/L')
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
Generated Narrative: Observation 072bc2ad-7ee7-4cce-9b4f-09a98df61971 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 8.7 U/L (Details: UCUM codeU/L = 'U/L') interpretation: Low ReferenceRanges - Low High * 10 U/L (Details: UCUM codeU/L = 'U/L') * 40 U/L (Details: UCUM codeU/L = 'U/L')
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
Generated Narrative: Observation 71c73db3-4d99-4594-b92e-cbb5cc09b517 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Cholesterol [Mass/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 193.2 mg/dL (Details: UCUM codemg/dL = 'mg/dL') ReferenceRanges - Low High * 125 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 200 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Cholesterol [Mass/volume] in Serum or Plasma
Generated Narrative: Observation 762d6f8f-ec3d-445c-8547-f26ce553eedf Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Triglyceride [Mass/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 149.3 mg/dL (Details: UCUM codemg/dL = 'mg/dL') ReferenceRanges - Low High * 0 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 199 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Triglyceride [Mass/volume] in Serum or Plasma
Generated Narrative: Observation 1e8a72c6-c4f4-4545-adcb-c5b542f86d7d Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 129.5 mg/dL (Details: UCUM codemg/dL = 'mg/dL') ReferenceRanges - Low High * 0 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 159 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay
Generated Narrative: Observation a78303a0-a824-499d-a76a-76e131d9dcb7 Profile: Observation: Medical Test Result (EU core) status: Final category: Laboratory code: Cholesterol in HDL [Mass/volume] in Serum or Plasma subject: Petra Schwartz Female, DoB: 1950-04-19 ( Jurisdictional health number) effective: 2024-07-15 performer: The Central European Lab value: 62.7 mg/dL (Details: UCUM codemg/dL = 'mg/dL') ReferenceRanges - Low High * 50 mg/dL (Details: UCUM codemg/dL = 'mg/dL') * 100 mg/dL (Details: UCUM codemg/dL = 'mg/dL')
Cholesterol in HDL [Mass/volume] in Serum or Plasma
Home nebulizer (physical object) 2021-06-21
Generated Narrative: Device b3c78022-b120-40c2-84e0-afe0e2d07c18 Profile: Device (EPS) udiCarrier id (01)16823880124549(11)210531(17)460615(10)48877640253395325(21)109490485862 status: Active type: Home nebulizer (physical object) patient: Petra Schwartz
Blood glucose meter (physical object) 1991-02-18
Generated Narrative: Device 575520ac-c2ef-4f47-82bf-1b691f5e6466 Profile: Device (EPS) udiCarrier id (01)70551104053281(11)910128(17)160212(10)34976447(21)50912 status: Active type: Blood glucose meter (physical object) patient: Petra Schwartz